Foghorn Therapeutics Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
![]() CCCC
C4 Therapeutics, Inc. |
$4.09 | $320.64 M | -1.97 | 110 | $20.76 M |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() CSBR
Champions Oncology, Inc. |
$9.47 | $62.53 M | -6.39 | 210 | $50.16 M |
![]() CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 | $0 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() IPSC
Century Therapeutics, Inc. |
$1.05 | $244.54 M | -1.32 | 152 | $2.24 M |
![]() KYMR
Kymera Therapeutics, Inc. |
$39.90 | $2.02 B | -13.13 | 188 | $47.07 M |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() MNOV
MediciNova, Inc. |
$2.16 | $67.19 M | -8.06 | 13 | $1.00 M |
![]() MOLN
Molecular Partners AG |
$5.06 | $135.05 M | -2.03 | 158 | $4.97 M |
![]() NRIX
Nurix Therapeutics, Inc. |
$19.22 | $930.10 M | -5.89 | 286 | $54.55 M |
![]() PMVP
PMV Pharmaceuticals, Inc. |
$1.57 | $85.40 M | -1.26 | 47 | $0 |
![]() PRLD
Prelude Therapeutics Incorporated |
$1.33 | $205.99 M | -2.02 | 131 | $7.00 M |
![]() RZLT
Rezolute, Inc. |
$5.21 | $229.57 M | -5.02 | 64 | $0 |
![]() STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
![]() STTK
Shattuck Labs, Inc. |
$1.27 | $333.81 M | -3.64 | 75 | $1.66 M |